Magnetic resonance colonography assessment of acute trinitrobenzene sulfonic acid colitis in pre-pubertal rats.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 11 07 2021
accepted: 14 10 2021
entrez: 4 11 2021
pubmed: 5 11 2021
medline: 24 12 2021
Statut: epublish

Résumé

Pre-pubertal murine models of acute colitis are lacking. Magnetic resonance colonography (MRC) is a promising minimally invasive tool to assess colitis. We aimed to: 1/ Adapt a model of acute experimental colitis to pre-pubertal rats and determine whether MRC characteristics correlate with histological inflammation. 2/ Test this model by administering a diet supplemented in transforming growth factor β2 to reverse inflammation. Twenty-four rats were randomized at weaning to one of 3 groups: Trinitrobenzene Sulfonic Acid (TNBS) group (n = 8) fed a standard diet, that received an intra-rectal 60 mg/kg dose of TNBS-ethanol; Control group (n = 8) fed standard diet, that received a dose of intra-rectal PBS; TNBS+MODULEN group (n = 8) that received a dose of TNBS and were exclusively fed MODULEN-IBD® after induction of colitis. One week after induction of colitis, rats were assessed by MRC, colon histopathology and inflammation markers (Interleukin 1β, Tumor necrosis factor α, Nitric Oxide Synthase 2 and Cyclooxygenase 2). TNBS induced typical features of acute colitis on histopathology and MRC (increased colon wall thickness, increased colon intensity on T2-weighted images, target sign, ulcers). Treatment with MODULEN-IBD® did not reduce signs of colitis on MRC. Inflammatory marker expression did not differ among study groups.

Identifiants

pubmed: 34735489
doi: 10.1371/journal.pone.0259135
pii: PONE-D-21-22589
pmc: PMC8568272
doi:

Substances chimiques

Interleukin-1beta 0
Tumor Necrosis Factor-alpha 0
Trinitrobenzenesulfonic Acid 8T3HQG2ZC4
Nitric Oxide Synthase Type II EC 1.14.13.39
Cyclooxygenase 2 EC 1.14.99.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0259135

Déclaration de conflit d'intérêts

No authors have competing interests.

Références

Am J Gastroenterol. 2018 Feb;113(2):265-272
pubmed: 28809388
J Pediatr Gastroenterol Nutr. 2003 Oct;37(4):481-6
pubmed: 14508220
PLoS One. 2014 Jul 07;9(7):e100921
pubmed: 25000184
J Crohns Colitis. 2019 Jul 25;13(7):846-855
pubmed: 30541015
Nutrients. 2020 Mar 20;12(3):
pubmed: 32245085
PLoS Biol. 2010 Jun 29;8(6):e1000412
pubmed: 20613859
Inflamm Bowel Dis. 2012 Oct;18(10):1940-9
pubmed: 22262626
Inflamm Bowel Dis. 2010 Jun;16(6):953-61
pubmed: 19834970
J Immunol Res. 2019 Dec 1;2019:7247238
pubmed: 31886308
Am J Physiol Gastrointest Liver Physiol. 2019 Jun 1;316(6):G692-G700
pubmed: 30735453
Scand J Gastroenterol. 2017 Jan;52(1):5-10
pubmed: 27553420
J Crohns Colitis. 2020 Oct 07;:
pubmed: 33026087
Curr Protoc Mouse Biol. 2017 Mar 2;7(1):13-28
pubmed: 28252200
Aliment Pharmacol Ther. 2000 Mar;14(3):281-9
pubmed: 10735920
J Pediatr Gastroenterol Nutr. 2010 Mar;50(3):240-50
pubmed: 20118800
Int Rev Immunol. 2000;19(1):51-62
pubmed: 10723677
Inflamm Bowel Dis. 2015 Jun;21(6):1248-59
pubmed: 25989337
Dig Liver Dis. 2019 Apr;51(4):496-502
pubmed: 30611597
Aliment Pharmacol Ther. 1994 Dec;8(6):609-15
pubmed: 7696450
Aliment Pharmacol Ther. 2018 Dec;48(11-12):1232-1241
pubmed: 30345577
Inflammopharmacology. 2016 Jun;24(2-3):109-18
pubmed: 27038922
Inflamm Bowel Dis. 2013 Feb;19(2):378-85
pubmed: 22573581
Gastroenterology. 2003 Dec;125(6):1750-61
pubmed: 14724828
World J Gastroenterol. 2018 Jul 7;24(25):2741-2763
pubmed: 29991879
Pharmacol Res. 2019 Mar;141:591-601
pubmed: 30711419
Ann Med Surg (Lond). 2016 Aug 19;11:9-15
pubmed: 27656280
Isr Med Assoc J. 2008 Jul;10(7):503-7
pubmed: 18751627
Dig Dis Sci. 2005 Jan;50(1):143-150
pubmed: 27837390
Gastroenterology. 1989 Mar;96(3):795-803
pubmed: 2914642
Behav Res Methods. 2007 May;39(2):175-91
pubmed: 17695343
Gastroenterology. 2012 Jan;142(1):46-54.e42; quiz e30
pubmed: 22001864
Mediators Inflamm. 2018 Feb 15;2018:8430614
pubmed: 29670469
J Nutr Biochem. 2013 Apr;24(4):700-5
pubmed: 22841543
Gut. 2000 May;46(5):694-700
pubmed: 10764714
PLoS One. 2013;8(1):e54543
pubmed: 23382912
Signal Transduct Target Ther. 2017;2:
pubmed: 29158945
World J Gastroenterol. 2017 Sep 7;23(33):6016-6029
pubmed: 28970718

Auteurs

Claire Dupont-Lucas (C)

INSERM UMR 1073, Institute for Biomedical Research, Rouen University, Rouen, France.

Rachel Marion-Letellier (R)

INSERM UMR 1073, Institute for Biomedical Research, Rouen University, Rouen, France.

Mathilde Pala (M)

INSERM UMR 1073, Institute for Biomedical Research, Rouen University, Rouen, France.

Charlène Guerin (C)

INSERM UMR 1073, Institute for Biomedical Research, Rouen University, Rouen, France.

Christine Bôle-Feysot (C)

INSERM UMR 1073, Institute for Biomedical Research, Rouen University, Rouen, France.

Emmeline Salameh (E)

INSERM UMR 1073, Institute for Biomedical Research, Rouen University, Rouen, France.

Alexis Goichon (A)

INSERM UMR 1073, Institute for Biomedical Research, Rouen University, Rouen, France.

Lionel Nicol (L)

INSERM UMR 1096, Institute for Biomedical Research, Rouen University, Rouen, France.

Moutaz Aziz (M)

Department of Pathology, Rouen University Hospital, Rouen, France.

Céline Savoye-Collet (C)

QUANTIF-LITIS EA 4108, Rouen University, Rouen, France.

Guillaume Savoye (G)

Department of Gastroenterology, Rouen University Hospital, Rouen, France.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH